Health Care Select Sector SPDR® ETF (XLV)
81.58
+0.00 +0.00%
NYSE Arca
Sep 22, 20:00
Delayed 2m
USD
XLV Key Stats
| Expense Ratio | 0.14% |
| Share Class Assets Under Management | 18.38B |
| 30-Day Average Daily Volume | Upgrade |
| Net Asset Value | 81.62 |
| Discount or Premium to NAV | -0.05% |
| Turnover Ratio | 8.00 |
View All XLV News
XLV News
-
WireHeadlineTime (ET)
-
Yahoo09/22 14:25
-
SA Breaking News09/22 14:21
-
MT Newswires09/22 13:24
-
MT Newswires09/22 09:20
-
MT Newswires09/21 13:26
-
MT Newswires09/21 09:28
-
SA Breaking News09/21 07:30
-
MT Newswires09/20 13:26
-
Yahoo09/20 10:38
-
Yahoo09/20 10:18
XLV Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 3.25% | 3.34% | 4.52% | 65 |
| 3M | 1.60% | 1.67% | 1.61% | 38 |
| 6M | 10.37% | 10.37% | 11.71% | 60 |
| 1Y | 12.99% | 13.00% | 11.41% | 48 |
| 3Y | 9.76% | 9.79% | 8.68% | 38 |
| 5Y | 17.03% | 17.02% | 16.37% | 47 |
| 10Y | 10.63% | 10.65% | 11.64% | 63 |
XLV Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.00 | 0.00 | 0.00 |
| Stock | 99.60% | 99.60% | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Convertible | 0.00 | 0.00 | 0.00 |
| Preferred | 0.00 | 0.00 | 0.00 |
| Other | 0.40% | 0.40% | 0.00 |
XLV Region Exposure
| Americas | 100.0% |
| North America | 100.0% |
| Latin America | 0.00 |
| Greater Europe | 0.00 |
| United Kingdom | 0.00 |
| Europe Developed | 0.00 |
| Europe Emerging | 0.00 |
| Africa/Middle East | 0.00 |
| Greater Asia | 0.00 |
| Japan | 0.00 |
| Australasia | 0.00 |
| Asia Developed | 0.00 |
| Asia Emerging | 0.00 |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00 |
XLV Stock Sector Exposure
| Basic Materials | 0.00 |
| Communication Services | 0.00 |
| Consumer Cyclical | 0.00 |
| Consumer Defensive | 0.00 |
| Energy | 0.00 |
| Financial Services | 0.00 |
| Healthcare | 99.30% |
| Industrials | 0.00 |
| Real Estate | 0.00 |
| Technology | 0.70% |
| Utilities | 0.00 |
XLV Stock Market Capitalization
| Giant | 52.37% |
| Large | 37.83% |
| Medium | 9.70% |
| Small | 0.10% |
| Micro | 0.00 |
XLV Stock Style Exposure
| Large Cap Value | 24.68% |
| Large Cap Blend | 36.73% |
| Large Cap Growth | 28.80% |
| Mid Cap Value | 1.70% |
| Mid Cap Blend | 3.31% |
| Mid Cap Growth | 4.69% |
| Small Cap Value | 0.10% |
| Small Cap Blend | 0.00 |
| Small Cap Growth | 0.00 |
View More Holdings
As of Sept. 22, 2017
XLV Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 11.20% | 131.39 | -0.27% |
| PFE | Pfizer Inc | 6.81% | 35.96 | -0.03% |
| UNH | UnitedHealth Group Inc | 5.97% | 193.03 | -1.12% |
| MRK | Merck & Co Inc | 5.66% | 65.13 | -0.72% |
| ABBV | AbbVie Inc | 4.43% | 87.48 | +0.08% |
| AMGN | Amgen Inc | 4.30% | 185.76 | -0.47% |
| CELG | Celgene Corp | 3.57% | 143.89 | +0.08% |
| GILD | Gilead Sciences Inc | 3.45% | 83.27 | +0.79% |
| MDT | Medtronic PLC | 3.44% | 79.70 | +0.21% |
| BMY | Bristol-Myers Squibb Company | 3.32% | 63.36 | +0.05% |
Advertisement
XLV One Page Reports
- One Page Report Download
XLV Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | SPDR State Street Global Advisors |
| Benchmark Index | |
|---|---|
S&P Health Care Select Sector TR USD |
100.0% |
XLV Manager Info
| Name | Tenure |
|---|---|
| Dwayne Hancock | 0.66 yrs |
| Karl Schneider | 2.58 yrs |
| Michael Feehily | 6.59 yrs |
XLV Net Fund Flows
| 1M | -662.00M |
| 3M | 229.19M |
| 6M | 96.87M |
| YTD | 1.435B |
| 1Y | 2.887B |
| 3Y | 3.598B |
| 5Y | 6.014B |
| 10Y | 8.272B |
XLV Risk Info
| Beta (5Y) | 0.9145 |
| Max Drawdown (All) | 40.58% |
| Historical Sharpe (10Y) | 0.8107 |
| Historical Sortino (All) | 0.7129 |
| 30-Day Rolling Volatility | 9.86% |
| Daily Value at Risk (VaR) 1% (All) | 3.03% |
| Monthly Value at Risk (VaR) 1% (All) | 13.26% |
XLV Fundamentals
| Dividend Yield TTM (9-22-17) | 1.46% |
| SEC Yield (9-22-17) | 1.44% |
| Weighted Average PE Ratio | 23.41 |
| Weighted Average Price to Sales Ratio | 1.899 |
| Weighted Average Price to Book Ratio | 3.935 |
| Weighted Median ROE | 22.80% |
| Weighted Median ROA | 8.16% |
| Forecasted Dividend Yield | 1.68% |
| Forecasted PE Ratio | 21.99 |
| Forecasted Price to Sales Ratio | 1.784 |
| Forecasted Price to Book Ratio | 3.526 |
| Number of Holdings | 63 |
XLV Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.17% |
| Forecasted Book Value Growth | 9.14% |
| Forecasted Cash Flow Growth | 14.50% |
| Forecasted Earnings Growth | 11.39% |
| Forecasted Revenue Growth | 9.94% |
XLV Comparables
EditXLV Attributes
| Key Dates | |
|---|---|
| Inception Date | 12/16/1998 |
| Last Annual Report Date | 9/30/2016 |
| Last Prospectus Date | 1/31/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | Yes |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
XLV Excel Add-In Codes
- Name: =YCI("XLV","name")
- Broad Asset Class: =YCI("XLV", "broad_asset_class")
- Broad Category: =YCI("XLV", "broad_category_group")
- Prospectus Objective: =YCI("XLV", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
